A new meta-analysis including data from 60 million individuals over 8 years has demonstrated significant decreases in HPV infections, anogenital wart diagnoses and precancerous cervical lesions following HPV vaccination in girls.
We spoke to Sally Roberts (University of Birmingham, UK) at the recent Microbiology Society Conference (8–11 April, Belfast, UK) about her lab’s models for studying HPV and the virus–host interactions that have been uncovered as a result of this.
An international team of researchers have successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells, which had been transplanted into mice.
The Joint Committee on Vaccination and Immunisation has stated that a gender-neutral vaccine program would be cost effective in the UK and would protect boys against HPV infection and associated diseases.
A recent study has demonstrated a significant decrease in cases of human papilloma virus infection in England since the introduction of a bivalent vaccine in 2008.
A study presented at ASCO this weekend has suggested that antibiotic use greatly reduces the progression-free survival and overall survival of cancer patients receiving immunotherapy.
Scientists have revealed that a human protein – identified as YTHDF2 – could prevent cancer by restricting the human herpes virus 8, otherwise known as Kaposi’s sarcoma-associated herpesvirus.
Research in mice and cell lines has demonstrated the potential of Zika virus to target and kill glioblastoma stem cells, suggesting a possible new treatment for this brain cancer.
Researchers have suggested that a virion protein known as BNRF1, produced by the Epstein–Barr Virus, may be responsible for tumor formation.